44 jobs for “Biotech Research Scientist”
Alloy Therapeutics UK Ltd Cambridge £45,000 – £50,000 pa
Design and build large-scale synthetic gene loci and transgenic platforms for antibody discovery, using CRISPR/Cas9, RMCE and site-specific integrases. Hands-on molecular biology including PCR, NGS, plasmid construction and flow-cytometric immunophenotyping, within a small multidisciplinary team working from dry-lab design to wet-lab validation.
CureAge Therapeutics London
Lead the computationally guided design of a lipid nanoparticle delivery platform, applying chemical and biophysical principles to optimise LNP composition and formulation. Use AI-enabled chemistry, cheminformatics, predictive models and molecular modelling to prioritise formulation components, working closely with the experimental team and founding team in a small start-up.
GSK USA - Pennsylvania - Upper Providence £174,750 – £291,250 pa
Leads respiratory epidemiology and real-world evidence programs that inform vaccine development, accountable for at least one asset or disease area and its Global Epidemiology Plan. Designs and oversees complex observational studies using claims, EHR and registry data, advises clinical, safety and regulatory matrix teams, and manages external partnerships and scientific dissemination. Also mentors junior epidemiologists and represents the company with regulators and at international conferences.
GSK Boston, United States £174,750 – £320,375 pa
Leads respiratory epidemiology and real-world evidence programs that inform vaccine development, designing and overseeing complex studies on disease burden, treatment patterns and safety. Partners across clinical development, safety, regulatory and health outcomes, manages external collaborations, and mentors junior scientists. Hybrid role requiring on-site presence at least two days per week.
Relation Therapeutics London
Lead the team behind hybrid on-prem and cloud compute infrastructure, Kubernetes clusters, and scientific compute environments supporting ML and drug discovery. Own platform strategy, CI/CD maturity, observability, and security controls for sensitive patient-derived data, reporting to the VP of Engineering.
Isomorphic Labs London
Lead all externalised drug discovery and preclinical lab operations, building and scaling a global CRO infrastructure for an AI-first drug design platform. Oversee experimental throughput, data QC and turnaround times, embed data-generation-by-design standards, and manage vendor governance, budgets and a team of CRO Scientific Leads, Operations Managers and Compound Managers.
Novartis London
Leads end-to-end translational strategy for neurodegenerative and neuromuscular programs, bridging preclinical research to Phase 1–2 clinical development. Accountable for biomarker strategy, clinical endpoint selection and early-phase trial design, and serves as the Translational Medicine representative within global cross-functional project and clinical trial teams.
Vertex Pharmaceuticals London
Leads the development and execution of international regulatory strategy across European and Rest of World markets, from first-in-human through post-marketing. Represents Global Regulatory Affairs on core development teams, manages project plans and resources, and advises senior management. Also a people manager within the International GRA leadership team, driving process improvement and regulatory policy engagement.
Relation Therapeutics London
Senior project manager role coordinating a multi-year osteoporosis drug discovery programme across target ID, hit-to-lead, lead optimisation and candidate selection. Involves orchestrating matrixed wet lab, ML, data science and engineering teams plus CROs, managing plans, budgets, risks and governance, and translating scientific objectives into integrated timelines and milestones.
Ipsen London
Leads global operational delivery of early development oncology programs, managing Clinical Project Managers, Monitoring Leads and CTAs. Owns the clinical development plan, CRO and site selection strategy, budgets and timelines, and serves on Asset Teams. Requires deep first-in-human and Phase I oncology trial expertise.
Pfizer New York, United States US$176,600 – US$294,300 pa
Leads global evidence generation strategy for a rare disease therapy, overseeing HEOR studies such as network meta-analyses, economic models, and patient-reported outcomes. Partners with cross-functional teams and country affiliates to support reimbursement and market access, managing vendors and budgets. Requires deep HTA and health economics expertise within a matrix organization.
Pfizer Europe - Any Pfizer Site US$176,600 – US$294,300 pa
Leads global health economics and outcomes research for a rare disease asset, developing evidence generation strategy and HEOR studies such as network meta-analyses, economic models and patient-reported outcomes. Oversees launch deliverables including value dossiers and systematic literature reviews, working with cross-functional and country teams to support reimbursement and patient access.
CSL Maidenhead
Leads strategic sourcing and evaluation of external innovation opportunities in Haematology, identifying preclinical to Phase 1 assets and shaping early partnering strategies. Sits on the Therapeutic Area Leadership Team, co-leads New Product Opportunity reviews, drives cross-functional due diligence and works with Business Development on deal execution. Hybrid, three days a week at an R&D hub site.
CSL Opfikon, Switzerland
Leads strategic sourcing and evaluation of external innovation opportunities in Haematology, identifying preclinical to Phase 1 assets and shaping early partnering strategies. Sits on the Therapeutic Area Leadership Team, co-leads New Product Opportunity reviews, drives cross-functional due diligence, and works with Business Development on deal execution. Hybrid, three days a week at an R&D hub site.
Recursion Remote Opportunity - United Kingdom £136,500 – £167,200 pa
Lead clinical pharmacology and pharmacometrics strategy across a portfolio of rare disease and oncology programs, serving as the clinical pharmacology lead for regulatory interactions and study design from Phase 1-3. Perform and oversee modeling and simulation with tools such as WinNonlin, Monolix, NONMEM and R, and author regulatory sections for IBs, INDs and NDAs. Part of a Pharmacometrics team spanning clinical pharmacology, pharmacometrics and translational modeling, working end-to-end across discovery and development.
Isomorphic Labs Cambridge, United States
Lead and execute the translational medicine strategy for an oncology portfolio, ensuring clinical biomarker assay readiness and data delivery to inform mechanism of action, resistance and future indications. Serve as a core program team member and cancer biology expert, collaborating with AI and computational biology teams to build innovative biomarker analysis tools and advance companion diagnostics.
Recursion Salt Lake City, United States US$200,000 – US$220,500 pa
Lead a team of computational biologists in early discovery, acting as a player-coach who balances hands-on analysis with mentorship. Integrate phenomics, transcriptomics, genomics and proteomics data to nominate oncology and immunology targets, define validation criteria and precision medicine strategies, partnering with biologists, engineers and translational experts.
